Sjögren's syndrome--a plethora of clinical and immunological phenotypes with a complex genetic background (Q36951063)

17 August 2017

1 reference

title

Sjögren's syndrome--a plethora of clinical and immunological phenotypes with a complex genetic background (English)

1 reference

17 August 2017

1 reference

Karl A Brokstad

1 reference

17 August 2017

Roland Jonsson

1 reference

17 August 2017

Anne Isine Bolstad

series ordinal

1 reference

17 August 2017

Johan G Brun

series ordinal

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 June 2007

1 reference

Annals of the New York Academy of Sciences

17 August 2017

published in

1 reference

17 August 2017

volume

1108

1 reference

17 August 2017

page(s)

433-447

1 reference

Role of viruses in systemic lupus erythematosus and Sjögren syndrome

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.046

Genetic aspects of Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.046

Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.046

Cytokine polymorphisms in systemic lupus erythematosus and Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.046

Induction of interferon-alpha by immune complexes or liposomes containing systemic lupus erythematosus autoantigen- and Sjögren's syndrome autoantigen-associated RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.046

Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.046

Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.046

Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren’s syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.046

The BAFF/APRIL system in systemic autoimmune diseases with a special emphasis on Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.046

Programmed cell death in rheumatoid arthritis peripheral blood T-cell subpopulations determined by laser scanning cytometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.046

Role of B cells in Sjögren's syndrome--from benign lymphoproliferation to overt malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.046

Analysis of the molecular composition of Ro ribonucleoprotein complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.046

Cardiac expression of 52beta, an alternative transcript of the congenital heart block-associated 52-kd SS-A/Ro autoantigen, is maximal during fetal development

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.046

Ro/SSA autoantibodies directly bind cardiomyocytes, disturb calcium homeostasis, and mediate congenital heart block

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.046

The type I interferon system in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.046

Gene expression profiling of minor salivary glands clearly distinguishes primary Sjögren's syndrome patients from healthy control subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.046

Early pathogenic events associated with Sjögren's syndrome (SjS)-like disease of the NOD mouse using microarray analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.046

Genome-scale assessment of molecular pathology in systemic autoimmune diseases using microarray technology: a potential breakthrough diagnostic and individualized therapy-design tool

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.046

Mechanisms of Disease: primary Sjögren's syndrome and the type I interferon system

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.046

The lymphotoxin pathway: beyond lymph node development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.046

Lymphotoxin alpha/beta and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.046

Proteomics: the move to mixtures

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.046

Mass spectrometry technologies for proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.046

Identification of parotid salivary biomarkers in Sjogren's syndrome by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry and two-dimensional difference gel electrophoresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.046

Changes in salivary proteome following allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.046

Diagnostic potential of tear proteomic patterns in Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.046

IL-1 receptor antagonist (IL-1RA) gene polymorphism in Sjögren's syndrome and rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.046

Correlation between interleukin 10 gene promoter region polymorphisms and clinical manifestations in Japanese patients with Sjogren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.046

Association of transforming growth factor beta1 and tumor necrosis factor alpha polymorphisms with anti-SSB/La antibody secretion in patients with primary Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.046

Association of a new allele of the TAP2 gene, TAP2*Bky2 (Val577), with susceptibility to Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.046

RETRACTED: Infliximab in primary Sjögren's syndrome: one-year followup

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.046

Inefficacy of infliximab in primary Sjögren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjögren's Syndrome (TRIPSS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.046

Rituximab therapy and autoimmune disorders: prospects for anti-B cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.046

Rituximab treatment in patients with primary Sjögren's syndrome: an open-label phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.046

Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.046

Targeting BAFF: immunomodulation for autoimmune diseases and lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.046

Lymphoma and other malignancies in primary Sjögren's syndrome: a cohort study on cancer incidence and lymphoma predictors

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.046

Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.046

Progression of salivary gland dysfunction in patients with Sjogren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1422.046

RETRACTED: Infliximab in patients with primary Sjögren's syndrome: a pilot study

21 January 2018

0 references

Identifiers

DOI

10.1196/ANNALS.1422.046

1 reference

17 August 2017

1 reference